PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.\', \'Department of Internal Medicine, Monmouth Medical Center, Long Branch, New Jersey, USA.\', \'Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.\', \'Department of Pulmonary Medicine and Critical Care, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.\', \'Department of Pulmonary Medicine and Critical Care, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA Brent-Brown@ouhsc.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/jim-2021-002001
?:doi
?:hasPublicationType
?:journal
  • Journal of investigative medicine : the official publication of the American Federation for Clinical Research
is ?:pmid of
?:pmid
?:pmid
  • 34561232
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Tocilizumab in patients hospitalized with COVID-19 pneumonia: systematic review and meta-analysis of randomized controlled trials.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all